Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F373280 for Maintenance of Sinus Rhythm in AF and Heart Failure
NCT01831856Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Apr 2013
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 5
01
Overview
A Phase 2 trial of F373280 in Atrial fibrillation (AFib), sponsored by Pierre Fabre Laboratories. Started Apr 2013; status: completed.
02
Drugs
F373280
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01831856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01831856.